• Users Online: 198
  • Print this page
  • Email this page
  • Email this page
  • Email this page
  • Email this page

    Article Cited by others


Long-term effectiveness and safety of ixekizumab in the treatment of 14 patients with a history of chronic erythrodermic psoriasis who failed prior secukinumab: A bicentric retrospective study

Lo Yang, Huang Yu-Huei, Tsai Tsen-Fang

Year : 2021| Volume: 39| Issue : 2 | Page no: 87-88

   This article has been cited by
1 New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review
Po-Chien Wu, I-Hsin Huang, Chuang-Wei Wang, Cheng-Chang Tsai, Wen-Hung Chung, Chun-Bing Chen
American Journal of Clinical Dermatology. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Associations between HLA-Cw1 and Systemic Treatment Response of Asian Psoriasis Patients
Shin-Shin Ho, Tsen-Fang Tsai
Molecular Diagnosis & Therapy. 2022;
[Pubmed]  [Google Scholar] [DOI]
3 Biological treatment for erythrodermic psoriasis
Sunil Dogra, Hitaishi Mehta
Expert Opinion on Biological Therapy. 2022;
[Pubmed]  [Google Scholar] [DOI]
4 Infection risk in psoriatic patients receiving tumour necrosis factor inhibitors: a 20-year systematic review and meta-analysis of randomized controlled trials
Y.-C. Wang, Y.-H. Lin, S.-H. Ma, Y.-T. Chang, C.-C. Chen
Journal of the European Academy of Dermatology and Venereology. 2022;
[Pubmed]  [Google Scholar] [DOI]
5 Psoriasis and Dry Eye Disease: A Systematic Review and Meta-Analysis
Po-Chien Wu, Sheng-Hsiang Ma, Ya-Yun Huang, Jin-Yu Chang, Yun-Ting Chang, Ying-Xiu Dai
Dermatology. 2022; : 1
[Pubmed]  [Google Scholar] [DOI]


Read this article